-
-
NCT00369239
-
Primary Citation
Not Available
-
Data Specification
Not Available
You are not logged in.
Please login to continue selecting trials.
Trial Information
Generic NameRisperidoneProduct NameRISPERDAL®Therapeutic AreaBehaviors and Mental DisordersEnrollment303% Female39.5%% White98%
Product ClassAtypical AntipsychoticsSponsor Protocol NumberRISSCH4043Data PartnerJohnson & JohnsonCondition StudiedSchizophreniaMean/Median Age (Years)30.6
Supporting Documentation
- Collected Datasets Available
- Clinical Study Report Available
Approved Data Requests Associated with this Trial
- 2022-4992 : Temporal trajectories of side-effects associated with antipsychotic treatment ? An individual participant data meta-analysis
- 2021-4754 : Harnessing clinical trial data to inform real-world clinical decision making in the treatment of schizophrenia
- 2021-4705 : Inflammation and the Metabolic Syndrome in Psychosis
- 2019-3958 : Machine Learning for predicting treatment efficacy and clinical categorizations across mental health disorders.
- 2019-3827 : Prediction of outcome and adverse events in antipsychotic treatment
- 2017-1966 : Psychosis break through antipsychotic maintenance medication: An individual participant data meta-analysis